Case Report: Afatinib-Induced Interstitial Pneumonia: Experiences and Lessons From Two Patients

Background: Afatinib has shown good efficacy in patients harboring uncommon EGFR mutations, but the incidence of afatinib-induced interstitial pneumonia should be alert as its rapid progression. Here, we report two cases of interstitial pneumonia during afatinib treatment. Case presentation: The fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiao, Ma, Baozhen, Li, Tiepeng, Zhao, Lingdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548719/
https://www.ncbi.nlm.nih.gov/pubmed/34721009
http://dx.doi.org/10.3389/fphar.2021.698447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548719/
https://www.ncbi.nlm.nih.gov/pubmed/34721009
http://dx.doi.org/10.3389/fphar.2021.698447

Ejemplares similares